Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, October 22, 2020
CNS announced the Company's U.S. manufacturer, Pii, has completed the manufacturing process for Berubicin Drug Product, its lead drug candidate for GBM.
read more
Thursday, October 22, 2020
The Countq system from Verista is helping pharmaceutical companies accelerate COVID-19 vaccines from development to manufacturing with accelerated technology transfer.
read more
Vetter has moved into its new headquarters in Ravensburg, Germany.
read more
Valicare GmbH now offers additional services along the entire product life cycle of pharmaceutically and biotechnologically produced drugs.
read more
Heidelberg has signed a Master Service Agreement with ProBioGen for the antibodies used in two of their pipeline ATAC molecules.
read more
Catalent and BrainStorm an agreement for the manufacture of NurOwn, BrainStorm’s autologous cellular therapy being investigated for the treatment of ALS.
read more
LaunchWorks CDMO has been approved to manufacture and distribute Viral Transport Media, in accordance with Section IV.B of the FDA’s COVID-19 Transport Media Policy.
read more
Tuesday, October 27, 2020
Lonza announced a $93m investment in its CHI Division, a dosage form delivery partner to the biopharma and health nutrition industry.
read more
Tuesday, October 27, 2020
BrainStorm has selected RR&D as its partner to expedite site selection and design services for a state-of-the-art manufacturing facility for NurOwn in the U.S.
read more
Wednesday, October 28, 2020
Bayer AG and Asklepios BioPharmaceutical (AskBio) announced an agreement under which Bayer will acquire AskBio.
read more
Monday, November 02, 2020
Quantum Genomics has entered into an exclusive licensing and collaboration agreement with Xediton to develop and commercialize firibastat in Canada.
read more
Monday, November 02, 2020
AB2 Bio and WuXi Biologics have entered into a collaboration to set-up and accelerate commercial-scale manufacturing of Tadekinig alfa, AB2 Bio’s novel recombinant IL-18 binding protein.
read more
Monday, November 02, 2020
Catalent has signed an agreement with Bone Therapeutics to acquire its cell therapy manufacturing subsidiary, Skeletal Cell Therapy Support.
read more
Thursday, November 05, 2020
Taysha Gene Therapies and Catalent announced a partnership to support the development and manufacturing of Taysha’s gene therapies at Catalent’s Maryland-based gene therapy facilities.
read more
Thursday, November 05, 2020
Monaghan Medical Corporation (MMC) announced the opening of a new 65,000-square-foot facility that doubles the size of its previous headquarters building.
read more